Advancing Knowledge. Enhancing Care.
Advancing Knowledge. Enhancing Care.

Psoriasis News

the latest news from ipc, industry and others

Strober B, van de Kerkhof PCM, Callis Duffin K, Poulin Y, Warren RB, de la Cruz C, van der Walt JM, Stolshek BS, Martin ML, de Carvalho AVE

Am J Clin Dermatol. 2019 Jun 21. doi: 10.1007/s40257-019-00458-2. [Epub ahead of print]

Patient-reported outcome measures are important tools for capturing the patient experience and enhancing the patient-physician interaction. The Psoriasis Symptom Inventory (PSI) is a validated, 8-item instrument that assesses the severity of patient-reported psoriasis signs and symptoms. In 2017, IPC developed and executed a global study in partnership with Amgen that evaluated the practical usefulness of the PSI in clinical settings. The findings showed that completing the PSI questionnaire and subsequent discussion of the score with their physician encouraged patients to better communicate their experiences and treatment goals. Ultimately, understanding patients’ perspectives of their psoriasis symptoms will lead to patient-focused disease management. More information will be posted on the IPC website later this year regarding the availability of the PSI for clinical research and practice.

You can view the full article HERE.



Challenging cases in psoriasis: A focus on systemics, TB and pustular psoriasis

Wednesday, February 26, 2020
2:00 pm - 3:30 pm
Bangkok, Thailand
Register Now

Stay informed

Join the email list to receive the latest information on psoriasis meetings, manuscripts and research.

We use cookies on this website to enhance your experience. By continuing with this website, you consent to our use of cookies. Learn more.